Inflammatory pseudotumor of the skin mimicking non-melanoma skin cancer

Authors

  • Hemant Kumar Nautiyal Department of Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jollygrant, Dehradun, Uttarakhand, India
  • Priyank Pathak Department of Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jollygrant, Dehradun, Uttarakhand, India
  • Nadia Shirazi Department of Pathology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jollygrant, Dehradun, Uttarakhand, India
  • Ruchira Nautiyal Department of Gynaecology and Obstetrics, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jollygrant, Dehradun, Uttarakhand, India
  • Praveendra Kumar Sachan Department of Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jollygrant, Dehradun, Uttarakhand, India

DOI:

https://doi.org/10.18203/2349-2902.isj20170879

Keywords:

IPT, Non-melanoma, PCG, Skin cancer

Abstract

Inflammatory pseudo tumor (IPT) also known as inflammatory myofibroblastic tumor (IMT) or plasma cell granuloma (PCG) is mostly reported in viscera, with very rare primary cutaneous involvement. Its clinical presentation mimics non-melanoma skin cancers. This neoplasm, though considered benign, actually has intermediate biologic potential. We report a case of 52-year-old female who presented with a nodular lesion with central scab on face and hard sub mental lymph node. As patient refused for biopsy, FNAC was done, which showed highly atypical cells suggestive of squamous cell carcinoma from nodular lesion and reactive hyperplasia from lymph node. Patient underwent excision biopsy and supra-omohyoid lymph node dissection. Biopsy report showed it as inflammatory pseudo tumor of the skin and cervical lymph nodes showed non-caseating granuloma. We present review of this entity.

References

Umiker WO, Iverson LC. Post inflammatory tumor of the lung: Report of four cases simulating xanthoma, fibroma or plasma cell granuloma. J Thorac Surg. 1954;28:55-62.

Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol. 1998;15(2):102-1.

Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory to fibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15:85-101.

Czauderna P, Schaarschmidt K, Komasara L, Harms D, Lempe M, Vorpahl K, et al. Abdominal inflammatory masses mimicking neoplasia in children-experience of two centers. Pediatr Surg Int. 2005;21(5):346-50.

Matsubara O, Tan-Liu NS, Kenney RM, Mark EJ. Inflammatory pseudotumors of the lung: progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases. Hum Pathol. 1988;19(7):807-14.

Son SB, Heo YS, Shin WW, Oh TS, Song HJ, Oh CH. Case of cutaneous inflammatory myofibroblastic tumor. Ann Dermatol. 2010;22(1):91-5.

Cook JR, Dehner LP, Collins MH, Ma Z, Morris SW, Coffin CM, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001;25(11):1364-71.

Hurt MA, Santa Cruz DJ. Cutaneous inflammatory pseudotumor. Lesions resembling “inflammatory pseudotumors” or “plasma cell granulomas” of extracu-taneous sites. Am J Surg Pathol. 1990;14:764-73.

Gonzalez-Vela MC, Val-Bernal JF, Arce FP, Gomez-Roman J, Gonzalez-Lopez MA, Fernandez-Llaca JH. Presence of human herpesvirus-8 in inflammatory myofibroblastic tumor of the skin. J Eur Acad Dermatol Venereol. 2007;21:399-401.

Dehner LP. The enigmatic inflammatory pseudotumours: the current state of our understanding, or misunderstanding. J Pathol. 2000;192(3):277-9.

Sanders BM, West KW, Gingalewski C. Inflammatory pseudotumor of the alimentary tract: clinical and surgical experience. J Pediatr Surg. 2001;36(1):169-73.

Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859-72.

Lawrence B, Perez-Atayde A, Hibbard MK. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000;157:377-84.

Li XQ, Hisaoka M, Shi DR. Expression of anaplastic lymphoma kinase in soft tissue tumors an immunohistochemical and molecular study of 249 cases. Hum Pathol. 2004;35:711-21.

Coffin CM, Fletcher JA. Inflammatory myofibroblastictumour, in pathology and genetics of tumours of soft tissue and bone, C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., World Health Organization Classification of Tumours, IARC Press, Lyon, France; 2002:91-93.

Cerfolio RJ, Allen MS, Nascimento AG, Deschamps C, Trastek VF, Miller DL, et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg. 1999;67(4):933-6.

Maier HC, Sommers SC. Recurrent and metastatic pulmonary fibrous histiocytoma/plasma cell granuloma in a child. Cancer. 1987;60:1073-6.

Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31:509-20.

Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R, Koniaris LG. Inflammatory myofibroblastic tumors. J Surg Oncol. 2006;94(5):385-91.

El Shabrawi-Caelen LE, Katrin K, Cerroni L, Soyer HP, Kerl H. Cutaneous inflammatory pseudotumor-a spectrum of various diseases? J Cutan Pathol. 2004;31:605-11.

Downloads

Published

2017-02-25

Issue

Section

Case Reports